Ranbaxy eyes US pharma company - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Ranbaxy eyes US pharma company

Mar 3, 2000

Ranbaxy has mandated investment bankers Warburg Dillion Read and Rabo Bank to scout for international acquisitions preferably in the USA. Ranbaxy is among the top Indian pharmaceutical companies and ranks second in terms of domestic sales. It has interests in anti–infectives, respiratory and cardiovascular. It possesses 12 brands among the top 250 brands in the country and in terms of its therapeutic dosage offerings covers around 77% of the market.

The companies that are being talked about in this context are Sidmak Laboratories (which was earlier rumoured to be taken over by Wockhardt) and Schein Pharma. Both of these are players in the US generic markets and have distribution networks in place.

With almost $32 bn worth of drugs going off patent (more than 5 times the Indian market) in the USA, top Indian pharma companies are focusing on the US generic market to drive topline growth. Bottomline performance in this market is critically dependent on the time to the market. This is so since within the first two years prices of generic drugs drop almost 80%. Hence it is the first two entrants which make money on the introduction of a new drug in the generic market.

Also any company catering to the generic market needs to have a distribution network in place and it is for these reason that the Indian pharma companies such as Ranbaxy are looking at acquiring companies or putting in place alliances with the US based generic companies359


Equitymaster requests your view! Post a comment on "Ranbaxy eyes US pharma company". Click here!

  

More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

RANBAXY LAB SHARE PRICE


Apr 1, 2015 (Close)

TRACK RANBAXY LAB

  • Track your investment in RANBAXY LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS